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cases using Medicare claims
Jonathan D Mahnken1*, John D Keighley1, Douglas A Girod2, Xueyi Chen3 and Matthew S Mayo1Abstract
Background: Baseline and trend data for oral and pharyngeal cancer incidence is limited. A new algorithm was
derived using the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database to create an
algorithm to identify incident cases of oral and pharyngeal cancer using Medicare claims.
Methods: Using a split-sample approach, Medicare claims’ procedure and diagnosis codes were used to generate a
new algorithm to identify oral and pharyngeal cancer cases and validate its operating characteristics.
Results: The algorithm had high sensitivity (95%) and specificity (97%), which varied little by age group, sex, and
race and ethnicity.
Conclusion: Examples of the utility of this algorithm and its operating characteristics include using it to derive
baseline and trend estimates of oral and pharyngeal cancer incidence. Such measures could be used to provide
incidence estimates where they are lacking or to serve as comparator estimates for tumor registries.
Keywords: Medicare, Oral cancer, Secondary data analysis, SEERBackground
The Surgeon General’s report on oral health in America
stated that oral and craniofacial surveillance databases for
diseases, health services, and health care utilization are
limited or are lacking [1]. This report called for further
development and validation of outcome measures [1]. The
National Institute of Dental and Craniofacial Research
(NIDCR) noted similar concerns [2], and described the
need for baseline data in order to recognize trends over
time, particularly for underserved populations and less
common conditions among the general population [2].
Oral and pharyngeal (OP) cancers are diagnosed in
approximately 30,000 individuals in the United States
each year, and the annual mortality for OP cancer is
approximately 7,500 [1-3]. A large portion of OP cases
diagnosed are among individuals ages 65 years and older
[4]. Despite the large number of new cases each year, OP
cancer—relatively speaking—is a rare disease; so large
population-based settings are often required to answer
important research questions. Thus, we generated and* Correspondence: jmahnken@kumc.edu
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reproduction in any medium, provided the orvalidated an algorithm to identify incident OP cases
based on Medicare claims.
Investigators have utilized Medicare claims for cancer
and other health outcomes studies. Hospital, outpatient,
and physician claims can be reconfigured into longitudinal
databases. These can include diagnosis and procedure
codes, cost of services provided, as well as the correspon-
ding dates of these diagnoses and procedures.
Cooper et al. [5] studied the sensitivity of Medicare
data to identify incident prostate, lung, colorectal, breast,
pancreatic, and endometrial cancer cases. An algorithm
by Freeman et al. [6] to identify incident breast cancer
cases based on Medicare claims had high sensitivity
(90%), and also measured the specificity and positive pre-
dictive value of their algorithm. McClish and Penberthy [7]
used Medicare claims to quantify the number of missed
cases in the Virginia cancer registry. Medicare claims
created a unique opportunity for their work as it required
data from three separate sources—the Virginia cancer
registry, the Medicare Part A claims, and the Medicare Part
B claims. Mandelblatt et al. [8] and Mandelblatt et al. [9]
used the algorithm of Freeman et al. [6] to identify breast
cancer cases to investigate treatments and perceptions of
cancer treatment. Of particular interest to Mandelblattal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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algorithm developed by Freeman et al. [6], Nattinger et al.
[10] created a four-step algorithm to identify breast cancer
cases among the Medicare population and improved the
positive predictive value (≥89%) for identifying cases, while
still retaining high levels of sensitivity and specificity.
In this study the SEER-Medicare linked database was
used to derive an algorithm that identified incident OP
cancer cases among the elderly using only Medicare
claims. This algorithm may enable future studies to
address research questions about OP cancer through
secondary data analyses on Medicare claims. Individuals
identified by the algorithm can simultaneously be linked
to their medical records (Medicare claims) to assess
health trajectories. Estimates of OP cancer incidence rates
can also be derived using this algorithm for Medicare
beneficiaries, a large population-base inclusive of many




The SEER-Medicare linked database was used for this
study. The Center for Medicare and Medicaid Services
linked Surveillance, Epidemiology, and End Results
(SEER) tumor registry data with Medicare claims and
census information to create the SEER-Medicare linked
database. These data contained information on indivi-
duals with cancer, identified as being cases in the SEER
tumor registry, who also had Medicare insurance as
indicated by Medicare enrollment records. Nearly all
(97%) of the population ages 65 and older in the United
States have Medicare health insurance coverage [11],
which provides inpatient hospitalization, skilled nursing
facility, home health, and hospice care (Part A) coverage.
Most beneficiaries also have coverage for physician and
outpatient care services (Part B) [11]. Demographic in-
formation was also available from Medicare enrollment
files, including membership in Health Maintenance
Organizations, or HMOs [11]. For this study, only
inpatient (Part A) and physician and outpatient (Part B)
Medicare claims were used. Previous investigations of
the SEER-Medicare database indicated that approxi-
mately 93.6% of the cases in SEER tumor registry were
also included in the SEER-Medicare database for sub-
jects ages 65 years old and older [12].
The SEER-Medicare linked database consisted of two
types of denominator files, the Patient Entitlement and
Diagnosis Summary File (PEDSF) and Summarized
Denominator File (SumDenom). The PEDSF file con-
tained patient demographics collected by both SEER
and the Social Security Administration. These included
measures such as date of birth, race, ethnicity, county
of residence, Medicare eligibility, HMO membershipand date of death. Only individuals diagnosed in a SEER
registry with cancer were included in the PEDSF file; thus
tumor measures (e.g., cancer site, date of diagnosis, stage
of tumor, etc.) from SEER were also included in these files.
Our PEDSF file included patients in the SEER-Medicare
linked database whose cancer diagnosis took place from
1973 to 2002. We obtained 100% files for subjects with
OP cancers diagnosed during these years. Subjects with
cancers other than OP cancer were not included in these
analyses. The SumDenom file contained similar demo-
graphic information to the PEDSF, with its information
gathered solely from the Social Security Administration.
The information in the SumDenom file was a 5% sample
of individuals living in SEER areas that had not linked to a
SEER tumor registry. Information in our SumDenom file
covered the years 1986 through 2004.
The Medicare claims portions of the SEER-Medicare
linked database (inpatient, physician and outpatient files)
were related to one another through a common, subject-
specific identifier variable. The Medicare Provider Analysis
Review (MedPAR) files contained hospital inpatient claims.
These included ICD-9-CM diagnosis codes, ICD-9-CM
procedure codes, as well as the corresponding dates of the
diagnoses and procedures. The 100% Physician/Supplier
(physician) files were a subset of the National Claims
History files, and were referred to as the NCH files.
These data included ICD-9-CM diagnosis codes and a CPT
procedure code, along with the corresponding dates of
these diagnoses and procedures. The Outpatient Standard
Analytic (outpatient) files were also a subset of the National
Claims History files, and were referred to as the OutSAF
files. These data included ICD-9-CM diagnosis codes, ICD-
9-CM procedure codes, and a CPT procedure code with
accompanying dates.
Study cohort
A total of 3,050 incident OP cancer cases with a date of
diagnosis in the 2002 calendar year were identified. The
lower age limit for inclusion was 66 years to allow for
subjects aging into Medicare at age 65 to meet our prior
coverage criteria, leaving 2,751 cases. To ensure complete
information for each subject’s medical history, only sub-
jects with coverage by Medicare (Parts A and B) but not
by an HMO during the year before diagnosis through the
year after diagnosis (or through death for subjects that
died within a year of their diagnosis) were included. Fol-
lowing this exclusion, 1,807 OP cancer cases remained.
For non-cancer controls, 472,293 subjects were identified
from the SumDenom file as alive in 2002. A “pseudo-
diagnosis date” was randomly assigned as a date in the
2002 calendar year. (Alternative random assignment stra-
tegies would not likely influence the results as no temporal
trends pertaining to claims associated with OP cancer
incidence were anticipated.) A total of 368,666 controls
Mahnken et al. BMC Oral Health 2013, 13:1 Page 3 of 9
http://www.biomedcentral.com/1472-6831/13/1were at least 66 years of age on this pseudo-diagnosis data.
Utilizing the same inclusion/exclusion criteria for these
subjects for Medicare and no HMO coverage on the
pseudo-diagnosis date and its corresponding time window
left 242,654 non-OP cancer control subjects.
Study measures
OP cancers were identified using the SITE RECODE
variable from the PEDSF files. Integer values of 1–10
signified the following cancer sites (respectively): lip;
tongue; salivary gland; floor of mouth; gum and other
mouth; nasopharynx; tonsil; oropharynx; hypopharynx;
and other oral cavity and pharynx. For subjects with
more than one primary diagnosis at age 66 or older of
OP cancer, the occurrence diagnosed in the 2002 calen-
dar year was used. The representative sample of indi-
viduals that served as control subjects consisted of
observations from the SumDenom file. No variables
were needed to identify them as controls, as their
position in this 5% sample file identified them as being
a Medicare beneficiary living in a SEER area that had
not been diagnosed with cancer.
Evaluation of the performance of the algorithm across
various demographic characteristics was conducted in the
validation process. The following measures contained in
both PEDSF and SumDenom files were used for this
analysis: age group, sex, and race and ethnicity. Diagnosis
and procedure codes from Medicare claims were used for
the algorithm to predict whether an individual was an
incident OP cancer case or not (a control). The dates that
corresponded with these diagnoses and procedures were
also located in the Medicare claims, and were used to
limit the occurrence of such codes to within one year
(before or after) the potential date of incidence.
Building the algorithm
To generate our algorithm, 1,807 incident OP cancer
cases with a date of diagnosis in the 2002 calendar year
that met our inclusion criteria were identified. A total of
242,654 subjects from the SumDenom files that were
alive in 2002 and randomly assigned a “pseudo-diagnosis
date” in the 2002 calendar year. Medicare (MedPAR,
NCH, and OutSAF) claims for these subjects that had a
date within one year (one year before through one year
after) their diagnosis date/pseudo-diagnosis date were
selected. ICD-9 procedure codes and CPT procedure
codes from these claims were utilized. A 60% simple
random sample (without replacement) from these sub-
jects was selected to derive the algorithm (n=1,085 OP
cancer cases; n=145,548 controls), leaving the remaining
40% (n=722 OP cancer cases; n=97,106 controls) available
for validation. Contingency tables were generated to com-
pare demographic and clinical characteristics of the algo-
rithm building (60%) and validation (40%) samples. Thesecharacteristics were compared between samples using
Pearson’s chi-square test.
Medicare claims were used to generate weights for the
algorithm. Each claim source (MedPAR, NCH, and
OutSAF) was treated separately in the process that
follows. The first step in the algorithm was to reduce the
number of claim types. Thus, using the OP cases, only
procedures that had an ICD-9 diagnosis code for OP
cancer (values 140.XX-149.XX) at least 50% of the time
that the procedure occurred were retained. Next, the
relative frequencies of occurrence of (at least one) of
each of these unique ICD-9 procedure and CPT codes in
the claims among the OP cases were derived, and then
again among the controls. The log2 of the ratio of these
relative frequencies (of presence for each ICD-9 proce-
dure code and each CPT code within each claim source)
among the OP cases and among the controls was used
to generate a weight for each code. (For codes that oc-
curred only among the OP cases, the relative frequency
value used for the control subjects was one divided by
the number of controls plus one to avoid division by
zero.) Weights with a value less than or equal to four in
the ICD-9 procedure codes and CPT codes were set
equal to zero. (This was justified on the basis of low dis-
crimination between the relative frequencies among the
OP cases versus the controls.) A score for each OP case
and for each control was generated by summing the
weights for each code that was present during their two-
year window around their diagnosis/pseudo-diagnosis
dates. Weights for the presence of an ICD-9 diagnosis
code value of 140.XX-149.XX (OP cancer diagnosis
code) were also generated by taking the log2 of the ratio
of relative frequencies of occurrence of such a code
(in each data source) among the OP cases relative to the
non-cancer controls, then adding this weight to each
subject’s score. Formally, the equation for determining













where: CodesMed represented the various weights from
the ICD-9 procedure and diagnosis codes and CPT pro-
cedure codes defined above from the MedPAR data
source and xMed represented the corresponding indicator
variables (1 if present; 0 if not present) for whether the
subject had the code in their claims during the defined
time window; CodesNCH and xNCH represented these
values for the NCH data source; and CodesOut and xOut
represented them for the OutSAF data source.
Given the scores derived for each data source (MedPAR,
NCH, and OutSAF), the algorithm identified subjects as
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scores. Subjects with a value of zero in all three of these
scores were identified as not having OP cancer by the algo-
rithm. Histograms of the scores for each data source and
the combined source were presented for OP cancer cases
and controls. (Due to the size of the data source for the
controls, a simple random sample [without replacement] of
those not having OP cancer was used to select subjects for
these histograms.) Additional cut-points were also explored
and a receiver operating characteristics (ROC) curve [13]
was presented. The additional cut-points included the mini-
mum Euclidean distance from the point (0%, 100%) on the
ROC curve (representing 100% sensitivity and 100% speci-
ficity), and one that maximized specificity. Estimates for
sensitivity and specificity, along with their corresponding
95% confidence intervals [13] were generated for each of
these cut-points.
Validating the algorithm
Using the weights for each code used to derive the algo-
rithm, scores were generated for all of the Medicare
claims (MedPAR, NCH, and OutSAF) for each subject
during their individual time windows (centered on their
diagnosis date/pseudo diagnosis date) in the remaining
40% sample, called the validation sample. Subjects that
had a positive value in any one of these three scores were
identified by the algorithm as having OP cancer, and
those with a value of zero in all three of these scores were
identified as not having OP cancer. For comparison, the
algorithm was also evaluated at the additional cut-points
described above. The a priori research hypothesis was
that the algorithm derived would have sensitivity and
specificity values of at least 85% and 95%, respectively.
Point estimates and 95% confidence intervals for these
sensitivity and specificity [13] were also generated.
Variation in sensitivity and specificity by demographic
factors was also evaluated. Using the validation sample,
unconditional logistic regression models [14] predicting
cancer status as determined by the algorithm were
generated, first among those with OP cancer (for sensi-
tivity) and then among the controls (for specificity).
Backwards elimination was used to select the model
using age group, sex, and race and ethnicity. All possible
interactions were allowed, and the selection criterion
was set to p<0.1 (Wald test) to remain in the model.
The a priori research hypothesis was that the sensitivity
and specificity values would not vary by demographic
subgroups. Predicted probabilities and corresponding
95% confidence intervals were estimated [14]. Model fit
was evaluated using the Hosmer-Lemeshow goodness-
of-fit test [14].
Positive and negative predictive values were also
estimated for the algorithm on the validation sample.
These values represented: the probability that a subjectidentified by the algorithm as an OP cancer case was,
in fact, an OP cancer case (positive predictive value);
and the probability that a subject indicated by the algo-
rithm as a control subject truly did not have OP cancer
(negative predictive value). Because the controls repre-
sented only a 5% sample from that population, subjects
from this sample were weighted by a factor of 20 to
obtain an appropriate estimate for these values. Ninety
five percent confidence intervals [13] were estimated
for this inflated sample for these estimates.
This project was approved by The University of
Kansas Medical Center Human Subjects Committee
(HSC #10914). SAS versions 9.1, 9.2, and 9.3 (SAS
Institute, Cary, NC) were used for data management
and analyses.
Results
Among the OP cancer cases, the distributions of age
group, sex, and race and ethnicity were similar between
the algorithm building and validation samples. The same
was true for the control samples as well. These results
were presented in Table 1.
Algorithm built
The weights of each of the codes to generate overall
scores were presented (see Additional file 1: Appendix
Tables A-D). Using the cut-point of a positive (>0) score,
the sensitivity and specificity were 93.9% and 96.2%,
respectively. Histograms of the distributions of scores
among the OP cancer cases and controls were presented
in Figure 1. The ROC curve for various cut-points of the
algorithm score for indicating an OP cancer case was
presented in Figure 2, focusing only on values with high
specificity (>96%). This figure indicated that the value
with the smallest Euclidean distance from the point
(0%, 100%) on the ROC curve had high specificity. This
minimum distance occurred where the Medicare claims
score had a value >5.48, and produced a sensitivity of
93.8% and a 97.1% specificity. Using a more ad hoc
approach of prioritizing the maximization of specificity
(due to the relatively rare incidence of OP cancer), we
found that a cut-point of >37.43 had a sensitivity of
75.0% and a specificity of 99.3%. These results, along
with the corresponding 95% confidence intervals, were
presented in Table 2.
Validation of the algorithm
The various cut-point scores produced similar sensitivity
and specificity values to that of the algorithm building
sample. The initial cut-point score (>0 indicating the
algorithm identifying as an OP cancer case) had a sensi-
tivity of 95.3% and specificity of 96.0%. The sensitivity
and specificity for the minimum Euclidean distance cut-
point (>5.48) were 95.3% and 97.0%, respectively. For
Table 1 Frequency distributions (%) of the characteristics of the algorithm building and validation samples
Characteristic Algorithm building sample Validation sample Pearson’s x2 test p-value
OP cancer cases* 1,085 (100.0) 722 (100.0)
Age Group 66-69 201 (18.5) 116 (16.1) 0.1370
70-74 271 (25.0) 184 (25.5)
75-79 266 (24.5) 195 (27.0)
80-84 205 (18.9) 114 (15.8)
85 and older 142 (13.1) 113 (15.7)
Sex Female 417 (38.4) 287 (39.8) 0.5738
Male 668 (61.6) 435 (60.3)
Race and ethnicity Black 59 (5.4) 43 (6.0) 0.8859
Hispanic 17 (1.6) 9 (1.3)
Other 49 (4.5) 30 (4.2)
White 960 (88.5) 640 (88.6)
Non-cancer controls 145,548 (100.0) 97,106 (100.0)
Age Group 66-69 28,549 (19.6) 19,036 (19.6) 0.2610
70-74 36,729 (25.2) 24,269 (25.0)
75-79 33,361 (22.9) 22,597 (23.3)
80-84 24,635 (16.9) 16,479 (17.0)
85 and older 22,274 (15.3) 14,725 (15.2)
Sex Female 89,736 (61.7) 60,050 (61.8) 0.3564
Male 55,812 (38.4) 37,056 (38.2)
Race and ethnicity Black 10,385 (7.1) 7,148 (7.4) 0.0037
Hispanic 3,685 (2.5) 2,279 (2.4)
Other 8,681 (6.0) 5,897 (6.1)
White 122,797 (84.4) 81,782 (84.2)
*OP: oral and pharyngeal.
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tivity was 79.8% and specificity was 99.3%. These results,
along with the corresponding 95% confidence intervals,
were presented in Table 2.
The model for sensitivity indicated that the sensitivity
was lower for males than for females (p=0.0531). The
estimated sensitivity was 97.2% for females and 94.2% for
males. (Given the number of parameters in this model,
the Hosmer-Lemeshow goodness-of-fit test could not be
conducted.) The model for specificity was more complex.
The final model included age group (p<0.0001), sex
(p<0.0001), race and ethnicity (p=0.0158), and the age
group-by-race and ethnicity interaction (p=0.0072). No sig-
nificant lack-of-fit was detected for this model (p=0.5155).
All but one age group-by-sex-by-race and ethnicity sub-
group had an estimated specificity values exceeding 95%.
The group with specificity below this threshold was
Hispanic males ages 85 and older, and had a value of
94.0%. The estimated sensitivity and specificity values
and corresponding 95% confidence intervals from these
models were presented in Table 3. Notably, while statis-
tically significant variations were detected, sensitivity
and specificity values were similar across groups.The positive predictive values for each of these algo-
rithm cut-points were very low; although with the large
sample sizes the confidence intervals were narrow. The
initial cut-point score (>0 indicating the algorithm
identifying as an OP cancer case) had a value of 0.9%
(0.8-1.0%). For the minimum Euclidean distance cut-
point (>5.48) the positive predictive value was 1.2%
(1.1-1.2%). For the cut-point that maximized specificity
(>37.43), the positive predictive value was 4.0% (3.6-4.3%).
The negative predictive values, conversely, were extremely
high. For the initial and Euclidean distance cut-points,
these values were 100.0% (<100.0-100.0%). For the maxi-
mized specificity cut-point, the negative predictive value
was 99.9% (99.9-99.9%).
Discussion
A new algorithm based on Medicare claims to identify
incident OP cancer cases was created. This algorithm
used the relative frequency of occurrence of various
diagnosis and procedure codes to determine weights. By
summing these weights when present in individuals’
claims, scores were derived such that a higher score was
indicative of the algorithm identifying subjects as incident
Figure 1 Histograms of the scores based on Medicare claims source and their combined total*. *Oral and pharyngeal (OP) cancer case
(magenta) and control (blue) scores; vertical reference bars for: the initial cut-point score (>0 indicating the algorithm identifying as an OP cancer
case) that had a sensitivity of 93.9% and specificity of 96.2%, the minimal Euclidean distance cut-point (>5.48) that had a sensitivity of 93.8% and
specificity of 97.1%, and for the cut-point that maximized specificity (>37.43) that had 75.0% sensitivity and 99.3% specificity.
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pirical process that identified and scored various claims
from three different Medicare sources. Measures of sensi-
tivity and specificity exceeded a priori threshold values
(85% and 95%, respectively). Notably, the use of only a
subset of the three Medicare claims sources would nega-
tively impact the sensitivity by possibly missing claims that
would increase a score to indicate OP cancer, whereas this
would have a positive impact on specificity by not adding
to the score a claim from that source among subjects
without OP cancer.
The algorithm identified subjects as OP cancer cases
based on passing a score threshold based on their Medicare
claims. The impact of the removal of one or more of the
claims sources (MedPAR, NCH, and/or OutSAF) would,
therefore, modify (reduce) the sensitivity of the algorithm
by reducing the number of subjects identified as cases. In
contrast, the specificity would be increased as this would
reduce the potential of the algorithm miss-identifying a
control subject as an OP cancer case.
The utility of this algorithm depends on several factors.
For example, in trying to examine health trajectories overtime using Medicare claims, algorithms with a low posi-
tive predictive value may be of little use. This follows
from the fact that more subjects identified by the algo-
rithm as cases will actually be free of disease when the
positive predictive value is less than 50%. This is true
even for high values of sensitivity and specificity, as found
in the algorithm derived in this study. In comparison to
other algorithms, Freeman et al. [6] were able to identify
an algorithm cut-point for breast cancer that achieved
high sensitivity (90%) and specificity (>99%), and a posi-
tive predictive value exceeding 70%. The algorithm by
Nattinger et al. [10], also for breast cancer, increased the
positive predictive value to nearly 90%. Low positive
predictive values are a concern in situations, such as for
the algorithm derived in this study, where the underlying
disease is rare as near 100% specificity is required to have
a high positive predictive value. The extremely high
negative predictive value, conversely, could make this a
useful tool for a “rule out” decision when the algorithm
indicates the subject is OP cancer free (e.g., for a regis-
try trying to reduce the number of potential cases it
needs to follow-up).
Figure 2 Receiver operating characteristics (ROC) curve for scores based on Medicare claims for identifying incident oral and
pharyngeal cancer cases*. *Reference lines indicated: for the initial cut-point score (>0 indicating the algorithm identifying as an OP cancer
case) had a sensitivity of 93.9% and specificity of 96.2%; the sensitivity and specificity for the minimum Euclidean distance cut-point (>5.48) were
93.8% and 97.1%, respectively; and for the cut-point that maximized specificity (>37.43), sensitivity was 75.0% and specificity was 99.3%.
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this algorithm could be used despite the low positive
predictive value. For example, one could obtain Medicare
claims for regions not covered by a registry, or a registry
could use this algorithm as a point of comparison in
evaluating their completeness. Using Medicare claims, the
algorithm would indicate which subjects were indicated as
cases and which were not. The estimated positive pre-
dictive value (or its confidence interval boundaries) could
be multiplied by the number of algorithm-positive cases.
Similarly, the number of algorithm-negative subjects could
be multiplied by 100% minus the negative predictive value
(or its confidence interval boundaries) to estimate the num-
ber of cases missed by the algorithm. Summing the positive
predictive value-corrected number of algorithm-positive
subjects with the negative predictive value-corrected esti-
mate of the number of cases missed by the algorithm would
provide the estimated number of subjects with OP cancer.
In addition to baseline and trend data monitoring, this
approach could also be used for generating data for ecolo-
gic level analyses.Table 2 Sensitivity and specificity values for various score cut
Medicare claims score cut-point Sensitivity
>0.00 93.9 (92.5-95.3) /
>5.48 93.8 (92.4-95.3) /
>37.43 75.0 (72.5-77.6) /
*%; CI: confidence interval; algorithm building sample values/validation sample valuLimitations
The algorithm derived for this study used Medicare
beneficiaries diagnosed with OP cancer in 2002 and sub-
jects from a SEER area that did not link to the SEER
tumor registry. As noted previously, subjects with can-
cers other than OP cancer were not included in these
analyses. Consequently, the specificity (and thus positive
and negative predictive values) was (were) affected by
their exclusion. However, SEER estimated the (age-
adjusted) incidence of cancer in 2008 from all sites
among those ages 65 years and older at approximately
2,072/100,000 person-years [15]. Thus, the worst case
scenario is that the specificity would have been approxi-
mately 1-2% lower; but most likely the impact on specifi-
city would have been even less. Also pertaining to
subjects, this algorithm was derived among subjects at
least 66 years of age with Medicare coverage (and no
HMO coverage) during the time-window around the
diagnosis (and pseudo-diagnosis) dates as described
above. Thus, operating characteristics may be different
among subjects not meeting these criteria if such-points for the model building and validation samples
(95% CI)* Specificity (95% CI)*
95.3 (93.8-96.8) 96.2 (96.1-96.3) / 96.0 (95.9-96.2)
95.3 (93.8-96.8) 97.1 (97.0-97.2) / 97.0 (96.9-97.1)
79.8 (76.9-82.7) 99.3 (99.3-99.3) / 99.3 (99.2-99.3)
es.
Table 3 Adjusted sensitivity and specificity values for the
minimum Euclidean distance cut- point for the validation
samples
Sensitivity (95% confidence interval)
Females (regardless of age group and race and
ethnicity)
97.2 (94.5-98.6)
Males (regardless of age group and race and ethnicity) 94.0 (91.4-95.9)
Specificity (95% confidence interval)
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city in a systematic way. However, our results that assessed
for variation in sensitivity and specificity failed to detect age
variation in sensitivity, and while statistically significant, the
variations in specificity were minimal (Table 3).
Another limitation of this study was that the codes may
change over time. For example, entire coding systems
may be upgraded over time (e.g., shifting from ICD-9 to
ICD-10). Thus, use of such an algorithm for baseline and
trend estimates of OP cancer incidence among those 66
years of age and older may need periodic refinement
using the methods described above. The population of
interest may have different demographic characteristics
than those used to derive these measures. To account for
this, estimates could be done within various age group/
sex/race and ethnicity categories as needed using values
such as those presented in Table 3. While refinement can
update the algorithm with respect to its ability to identify
OP cancer cases within this large population of Medicare
beneficiaries, the utility of the weights to derive scores for
subjects in other important populations, such as those
less than 66 years of age, could not be evaluated with the
data used for this study. However, the approached
described could be applied to other data sources of simi-
lar structure, such as a large health insurance claims
source of hospital and clinic electronic medical records.
It is noteworthy that the sensitivity and specificity
of the algorithm were driven in part by the length of
time set to look for codes within the Medicare
claims. A longer window would increase the ability
to capture more codes—thereby allowing for sensi-
tivity to be increased, while a shorter window would
conversely benefit specificity. Further, the approach
does not provide an exact date of diagnosis; it does,
however, provide for an estimated window based on
the duration of time used to look for the various
claims.
Conclusions
Medicare claims data were used create a new algorithm
to identify incident cases of OP cancer. Though the
sensitivity and specificity for this algorithm were high,
the positive predictive value was low. Examples of the
utility of this algorithm and its operating characteristics
include using it to derive baseline and trend estimates of
OP cancer incidence. Such measures could be used to
provide incidence estimates where they are lacking or to
serve as comparator estimates for tumor registries.
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